Entocort EC Related Published Studies
Well-designed clinical trials related to Entocort EC (Budesonide)
Budesonide foam induces remission in patients with mild to moderate ulcerative
proctitis and ulcerative proctosigmoiditis. [2015]
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative
colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies. [2015]
Effects of nebulized high-dose budesonide on moderate-to-severe acute
exacerbation of asthma in children: a randomized, double-blind,
placebo-controlled study. [2013]
Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler(R) in Japanese Patients with Asthma: A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study. [2012.01.01]
Abatacept for Crohn's disease and ulcerative colitis. [2012]
AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in
patients with COPD. [2012]
Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma. [2011.12.01]
A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain. [2011.10]
Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. [2011.10]
Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial. [2011.09]
Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. [2011.08]
Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. [2011.07]
Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting. [2011.07]
Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. [2011.05]
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial. [2011.04]
Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide. [2011.04]
Budesonide quantification by HPLC coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry. Application to a comparative systemic bioavailability of two budesonide formulations in healthy volunteers. [2011.02.01]
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease. [2011.02]
Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD. [2011.02]
Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. [2011.01]
Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology. [2010.11]
Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. [2010.11]
Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. [2010.10]
Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. [2010.10]
Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma. [2010.09]
Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD. [2010.09]
Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study. [2010.09]
Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy. [2010.09]
Budesonide versus placebo in high-risk population with screen-detected lung nodules: Rationale, design and methodology. [2010.08.16]
Budesonide is Effective in Adolescent and Adult Patients With Active Eosinophilic Esophagitis. [2010.08.01]
Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis. [2010.08]
Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. [2010.08]
Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. [2010.08]
Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX(R) 9 mg extended-release tablets in patients with active left-sided ulcerative colitis. [2010.06]
Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. [2010.05.28]
Ketotifen versus inhaled budesonide for controlling childhood asthma. [2010.05]
Aerosolized L-epinephrine vs budesonide for post extubation stridor: a randomized controlled trial. [2010.04.07]
A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants. [2010.04]
Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma. [2010.03]
Effects of budesonide and fluticasone propionate in pediatric asthma patients. [2010.02]
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. [2010.02]
Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study. [2010.02]
Clinical assessment of levocetirizine and budesonide in treatment of persistent allergic rhinitis regarding to symptom severity. [2010.02]
Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma. [2010.01]
The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter. [2010.01]
Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. [2010]
Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study. [2010]
Impact of tiotropium on the course of moderate-to-very severe chronic obstructive
pulmonary disease: the UPLIFT trial. [2010]
Budesonide is effective in adolescent and adult patients with active eosinophilic
esophagitis. [2010]
The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. [2009.12]
Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study. [2009.12]
Airway and systemic effects of soluble and suspension formulations of nebulized budesonide in asthmatic children. [2009.11]
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. [2009.10.31]
Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. [2009.10.15]
Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma. [2009.10]
An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice. [2009.09.19]
Aerosolized L epinephrine vs Budesonide for Postextubation Stridor A Randomized Controlled Trial. [2009.09.03]
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma. [2009.09.01]
[Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation] [2009.09]
An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice. [2009.09]
Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. [2009.08]
Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations. [2009.07]
Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing. [2009.07]
Budesonide improves decreased airway conductance in infants with respiratory symptoms. [2009.07]
Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: a randomized placebo-controlled trial. [2009.07]
Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. [2009.06]
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. [2009.05]
Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. [2009.05]
High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. [2009.04]
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge. [2009.04]
The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. [2009.03]
Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. [2009.03]
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. [2009.02.19]
A proof-of-concept study to evaluate the antiinflammatory effects of a novel soluble cyclodextrin formulation of nebulized budesonide in patients with mild to moderate asthma. [2009.02]
Budesonide for maintenance of remission in Crohn's disease. [2009.01.21]
Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. [2009.01.05]
Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. [2009.01]
Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. [2009.01]
Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. [2009]
Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*. [2008.12]
Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole. [2008.11.15]
Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. [2008.11]
Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. [2008.11]
Effects of time, albuterol, and budesonide on the shape of the flow-volume loop in children with asthma. [2008.10]
Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. [2008.10]
Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults. [2008.10]
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma. [2008.10]
Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. [2008.09]
Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. [2008.09]
Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. [2008.09]
Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. [2008.08.22]
Oral Budesonide for Maintenance Treatment of Collagenous Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.08.07]
[Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study] [2008.08]
Atomization inhalation of terbutaline and budesonide efficiently improved immunity and lung function of AECOPD patients. [2008.08]
Budesonide for induction of remission in Crohn's disease. [2008.07.16]
Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. [2008.07]
Evidence of the in vivo esterification of budesonide in human airways. [2008.07]
Effect of disease duration on dose-response of inhaled budesonide in asthma. [2008.07]
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. [2008.05]
|